BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Dagan Lonsdale//NONSGML Clinical pharmacology year 1 calendar//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:0c17c81c-4635-4843-acfa-6cbe328fc4db
DTSTAMP:20250702T142452
DTSTART:19551009T140000
DTEND:19551009T150000
SUMMARY:PK Introduction to pharmacokinetics
DESCRIPTION:Module: PHA403, Person delivering: Toqa
LOCATION:Curve LT
END:VEVENT
BEGIN:VEVENT
UID:a75ac532-52ef-431c-95e8-df83d0ed00c3
DTSTAMP:20250702T142452
DTSTART:19551015T100000
DTEND:19551015T110000
SUMMARY:PK 1.1 Drug formulation
DESCRIPTION:Module: PHA403, Person delivering: Dagan/ Toqa
LOCATION:Curve LT
END:VEVENT
BEGIN:VEVENT
UID:d78ae750-b743-4cba-8fac-41a99343eaf4
DTSTAMP:20250702T142452
DTSTART:19551023T110000
DTEND:19551023T120000
SUMMARY:PK 1.2 Enteral administration
DESCRIPTION:Module: PHA403, Person delivering: Toqa
LOCATION:Curve LT
END:VEVENT
BEGIN:VEVENT
UID:32849848-b624-489b-826b-c8cf5880126d
DTSTAMP:20250702T142452
DTSTART:19551023T120000
DTEND:19551023T130000
SUMMARY:PK 1.3 Parenteral administration
DESCRIPTION:Module: PHA403, Person delivering: Dagan
LOCATION:Curve LT
END:VEVENT
BEGIN:VEVENT
UID:248b7660-1e76-4ed4-b2fb-703cf761983b
DTSTAMP:20250702T142452
DTSTART:19551029T150000
DTEND:19551029T160000
SUMMARY:PK 1.4 Drug absorption
DESCRIPTION:Module: PHA403, Person delivering: Toqa
LOCATION:LTF
END:VEVENT
BEGIN:VEVENT
UID:6e03412c-5a91-4938-99dd-17d72286e687
DTSTAMP:20250702T142452
DTSTART:19551103T140000
DTEND:19551103T150000
SUMMARY:PK 1.6 Drug distribution
DESCRIPTION:Module: PHA403, Person delivering: Toqa
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:20a7dc58-320e-467a-8f1e-c7f07fe1436f
DTSTAMP:20250702T142452
DTSTART:19551103T150000
DTEND:19551103T160000
SUMMARY:PK 1.6 Drug distribution
DESCRIPTION:Module: PHA403, Person delivering: Toqa
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:d3e2c742-e511-41fa-a10a-d78c1601ed40
DTSTAMP:20250702T142452
DTSTART:19551110T130000
DTEND:19551110T140000
SUMMARY:PK 1.8 Volume of distribution
DESCRIPTION:Module: PHA403, Person delivering: Toqa
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:b86401d7-2d20-4206-af01-49b3038ec7e5
DTSTAMP:20250702T142452
DTSTART:19551110T140000
DTEND:19551110T150000
SUMMARY:PK Volume of distribution - introduction to calculations
DESCRIPTION:Module: PHA403, Person delivering: Dagan
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:0e1b3df3-efdc-4f9c-8e48-fdfe2bffc259
DTSTAMP:20250702T142452
DTSTART:19551113T100000
DTEND:19551113T110000
SUMMARY:PK Introduction to visualising pharmacokinetic data using R
DESCRIPTION:Module: PHA403, Person delivering: Dagan
LOCATION:H5.1, H5.2 computing and H5.3 teaching
END:VEVENT
BEGIN:VEVENT
UID:0d071419-24a2-4033-9477-139c8fb5af65
DTSTAMP:20250702T142452
DTSTART:19551113T110000
DTEND:19551113T120000
SUMMARY:PK Introduction to visualising pharmacokinetic data using R
DESCRIPTION:Module: PHA403, Person delivering: Dagan
LOCATION:H5.1, H5.2 computing and H5.3 teaching
END:VEVENT
BEGIN:VEVENT
UID:e6b05092-3cff-4ae8-a588-e06a96a60f76
DTSTAMP:20250702T142452
DTSTART:19551119T120000
DTEND:19551119T130000
SUMMARY:PK 1.7 Drug metabolism by the liver 1
DESCRIPTION:Module: PHA403, Person delivering: Mark
LOCATION:LTF
END:VEVENT
BEGIN:VEVENT
UID:04351b44-a0cf-4864-b69b-616dfe50c7d1
DTSTAMP:20250702T142452
DTSTART:19551126T110000
DTEND:19551126T120000
SUMMARY:PK 1.9 Drug excretion including renal elimination
DESCRIPTION:Module: PHA403, Person delivering: Dagan
LOCATION:LTG
END:VEVENT
BEGIN:VEVENT
UID:5cac5790-cedb-4d18-b20e-f27f288c061a
DTSTAMP:20250702T142452
DTSTART:19551126T120000
DTEND:19551126T130000
SUMMARY:PK 1.10 Drug clearance
DESCRIPTION:Module: PHA403, Person delivering: Dagan
LOCATION:LTG
END:VEVENT
BEGIN:VEVENT
UID:bd2e72b6-d61f-45ec-be7a-026651455e39
DTSTAMP:20250702T142452
DTSTART:19551126T140000
DTEND:19551126T150000
SUMMARY:PK Joint workshop with fundamentals of science
DESCRIPTION:Module: PHA403, Person delivering: Dagan, Toqa, Jen
LOCATION:J0.7
END:VEVENT
BEGIN:VEVENT
UID:a1905ddc-36c3-4739-80ec-dd8b1e45eaa0
DTSTAMP:20250702T142452
DTSTART:19551127T140000
DTEND:19551127T150000
SUMMARY:PK Recap and review
DESCRIPTION:Module: PHA403, Person delivering: Toqa
LOCATION:J0.7
END:VEVENT
BEGIN:VEVENT
UID:a766a74e-a5c1-4d75-8aa4-3932ae4cd4a2
DTSTAMP:20250702T142452
DTSTART:19551127T150000
DTEND:19551127T160000
SUMMARY:PK Recap and review
DESCRIPTION:Module: PHA403, Person delivering: Toqa
LOCATION:J0.7
END:VEVENT
BEGIN:VEVENT
UID:f5ad7a75-9fc1-4892-81c6-f1d34a7dc08e
DTSTAMP:20250702T142452
DTSTART:19560104T140000
DTEND:19560104T150000
SUMMARY:PK Bioanalytical techniques
DESCRIPTION:Module: PHA403, Person delivering: Toqa
LOCATION:J0.7
END:VEVENT
BEGIN:VEVENT
UID:c8707374-360c-4d87-b7ec-93a352950a8e
DTSTAMP:20250702T142452
DTSTART:19560104T150000
DTEND:19560104T160000
SUMMARY:PK Bioanalytical techniques
DESCRIPTION:Module: PHA403, Person delivering: Toqa
LOCATION:J0.7
END:VEVENT
BEGIN:VEVENT
UID:d97e6031-f2a8-4617-a66c-b806aa6631ec
DTSTAMP:20250702T142452
DTSTART:19560114T150000
DTEND:19560114T160000
SUMMARY:PK 1.12 Therapeutic drug monitoring
DESCRIPTION:Module: PHA403, Person delivering: Toqa
LOCATION:Curve LT
END:VEVENT
BEGIN:VEVENT
UID:150cf2b9-d784-4284-8e18-a38eb1821d39
DTSTAMP:20250702T142452
DTSTART:19560202T100000
DTEND:19560202T110000
SUMMARY:PK 2.1 Non-compartmental analysis 
Group 1 90 mins
DESCRIPTION:Module: PHA403, Person delivering: Dagan
LOCATION:H1.8 and H1.9
END:VEVENT
BEGIN:VEVENT
UID:4c3bb811-df7c-4403-b8b1-71f389b88717
DTSTAMP:20250702T142452
DTSTART:19560202T110000
DTEND:19560202T120000
SUMMARY:PK 2.1 Non-compartmental analysis
DESCRIPTION:Module: PHA403, Person delivering: Dagan
LOCATION:H1.8 and H1.9
END:VEVENT
BEGIN:VEVENT
UID:1c97192c-c88c-4041-ad07-e5e3a2ff6631
DTSTAMP:20250702T142452
DTSTART:19560202T120000
DTEND:19560202T130000
SUMMARY:PK 2.1 Non-compartmental analysis 
Group 2 90 mins
DESCRIPTION:Module: PHA403, Person delivering: Dagan
LOCATION:H1.8 and H1.9
END:VEVENT
BEGIN:VEVENT
UID:5b85d7ef-d5b7-4feb-856a-2d02708fcefa
DTSTAMP:20250702T142452
DTSTART:19560211T120000
DTEND:19560211T130000
SUMMARY:PK 2.2 Introduction to PK of biologics
DESCRIPTION:Module: PHA403, Person delivering: Reya
LOCATION:Curve LT
END:VEVENT
BEGIN:VEVENT
UID:67bf0134-eaae-40d1-a307-0583b010c351
DTSTAMP:20250702T142452
DTSTART:19560225T110000
DTEND:19560225T120000
SUMMARY:PK 2.3 Renal disease and drug handling workshop
DESCRIPTION:Module: PHA403, Person delivering: Mark
LOCATION:J0.7
END:VEVENT
BEGIN:VEVENT
UID:1be5c0fc-3c68-494f-98bf-c0c7bc8b18ef
DTSTAMP:20250702T142452
DTSTART:19560225T120000
DTEND:19560225T130000
SUMMARY:PK 2.3 Renal disease and drug handling workshop
DESCRIPTION:Module: PHA403, Person delivering: Mark
LOCATION:J0.7
END:VEVENT
BEGIN:VEVENT
UID:ea54c122-def6-4048-9143-54f3d1ad9843
DTSTAMP:20250702T142452
DTSTART:19560315T110000
DTEND:19560315T120000
SUMMARY:PK 2.4 Liver disease and drug handling
DESCRIPTION:Module: PHA403, Person delivering: Cleodie
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:98178035-3eaf-47dc-8466-8df640c9db5b
DTSTAMP:20250702T142452
DTSTART:19560315T120000
DTEND:19560315T130000
SUMMARY:PK 2.4 Liver disease and drug handling
DESCRIPTION:Module: PHA403, Person delivering: Cleodie
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:965669df-91e5-44c4-a9b8-f43d373b3d33
DTSTAMP:20250702T142452
DTSTART:19560513T120000
DTEND:19560513T130000
SUMMARY:PK 2.5 Bioequivalence 1
DESCRIPTION:Module: PHA403, Person delivering: Toqa
LOCATION:Lecture theatre F
END:VEVENT
BEGIN:VEVENT
UID:84762fe3-7e71-4a3a-b9a5-bf5cdb7b3b71
DTSTAMP:20250702T142452
DTSTART:19560527T100000
DTEND:19560527T110000
SUMMARY:PK revision
DESCRIPTION:Module: PHA403, Person delivering: Toqa, Dagan
LOCATION:J0.7
END:VEVENT
BEGIN:VEVENT
UID:9537a852-c45d-45ae-9b2b-919e0a4a4bfc
DTSTAMP:20250702T142452
DTSTART:19560527T110000
DTEND:19560527T120000
SUMMARY:PK revision
DESCRIPTION:Module: PHA403, Person delivering: Toqa, Dagan
LOCATION:J0.7
END:VEVENT
BEGIN:VEVENT
UID:dfcfb205-87ef-4d27-bfe2-d7eb70b30b68
DTSTAMP:20250702T142452
DTSTART:19560527T120000
DTEND:19560527T130000
SUMMARY:PK revision
DESCRIPTION:Module: PHA403, Person delivering: Toqa, Dagan
LOCATION:J0.7
END:VEVENT
END:VCALENDAR
